Safety of Less-Radical Surgery for Early Cervical Cancer Gathers More Evidence
(MedPage Today) -- SAN DIEGO -- The safety of non-radical approaches to surgery in early, low-risk cervical cancer gained additional support from a new prospective study, though fertility preservation with cone biopsy also came with some cases... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 19, 2024 Category: Hematology Source Type: news

QOL Not Harmed With Add-On Pembrolizumab in Cervical Cancer QOL Not Harmed With Add-On Pembrolizumab in Cervical Cancer
Adding pembrolizumab to concurrent chemoradiotherapy does not affect quality of life in patients with high-risk locally advanced cervical cancer, new data show.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 18, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Laparoscopy Quickly Abandoned in Early Cervical Cancer After LACC Results
(MedPage Today) -- SAN DIEGO -- Oncologic surgeons rapidly abandoned minimally invasive surgery (MIS) for early-stage cervical cancer in the wake of a startling 2018 study that warned of the dangers of the approach for this patient population... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 18, 2024 Category: Hematology Source Type: news

Novel Drug-Device Shows Efficacy for High-Grade Cervical Lesions
(MedPage Today) -- SAN DIEGO -- A novel, noninvasive, photodynamic drug-device combination was efficacious and safe for patients with cervical histologic high-grade squamous intraepithelial lesions (HSIL), a randomized phase III trial showed... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 18, 2024 Category: Hematology Source Type: news

Does Vitamin D Protect Against Breast Cancer? Does Vitamin D Protect Against Breast Cancer?
A review article surveys the literature and considers dietary supplementation to achieve optimal vitamin D levels.Medscape UK (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 18, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news

BCI Registry Improves Breast Cancer Treatment Decisions BCI Registry Improves Breast Cancer Treatment Decisions
After using the BCI test assay, physicians adjusted their treatment recommendations for patients with hormone receptor –positive breast cancer, according to a new study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 18, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news

Immune Checkpoint Inhibitor-Chemo Combo Boosts OS in Advanced Endometrial Cancer
(MedPage Today) -- SAN DIEGO -- The addition of an immune checkpoint inhibitor (ICI) to chemotherapy up front improved overall survival (OS) in patients with advanced or recurrent endometrial cancer, regardless of mismatch repair (MMR) status... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 18, 2024 Category: Hematology Source Type: news

Raludotatug Deruxtecan Promising in Platinum-Resistant Advanced Ovarian Cancer
(MedPage Today) -- SAN DIEGO -- Treatment with raludotatug deruxtecan (R-DXd) led to an "exciting" response rate among patients with heavily pretreated, platinum-resistant advanced ovarian cancer, according to an early-phase trial. In a subgroup... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 17, 2024 Category: Hematology Source Type: news

FDA Approves First CAR T-Cell Therapy for rrCLL, rrSLL FDA Approves First CAR T-Cell Therapy for rrCLL, rrSLL
The accelerated approval for liso-cel was based on findings showing 20% of patients achieved a complete response from a one-time infusion after at least two prior lines of therapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 15, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Customized Radiation of Uterus May Not Compromise Outcomes Customized Radiation of Uterus May Not Compromise Outcomes
Researchers found that patients with locally advanced cervical cancer who received less than whole uterus irradiation had low local recurrence rates and fewer side effects.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 15, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Gilead CAR-T Cancer Therapy Capacity to Quadruple by 2026 Gilead CAR-T Cancer Therapy Capacity to Quadruple by 2026
Gilead Sciences will be able to quadruple production of its cell therapy cancer treatments by 2026 due to improvements in the U.S. biotech ' s manufacturing processes, an...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 15, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Look Beyond BMI: Metabolic Factors' Link to Cancer Explained Look Beyond BMI: Metabolic Factors' Link to Cancer Explained
Researchers delve deeper into metabolic syndrome trajectories finding that adults with persistent and worsening metabolic syndrome over time are at increased risk for any type of cancer.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 15, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news

FDA Approves New Esophageal Cancer Drug FDA Approves New Esophageal Cancer Drug
The checkpoint inhibitor is approved for second-line treatment of patients with esophageal squamous cell carcinoma after prior systemic chemotherapy that did not include a PD-L1 inhibitor.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 15, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Geron's Blood Disorder Drug Gets FDA Advisers' Backing Geron's Blood Disorder Drug Gets FDA Advisers' Backing
Advisers to the U.S. Food and Drug Administration on Thursday backed benefits of Geron ' s blood disorder drug, saying it outweighed the risks associated with the treatment,...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 14, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Cancer Prevention Beliefs: Where Have We Gone Wrong? Cancer Prevention Beliefs: Where Have We Gone Wrong?
Professor David Kerr discusses beliefs and attitudes toward cancer prevention.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 14, 2024 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news